These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27977588)

  • 1. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.
    Liu Y; Chen S; Sun Y; Lin Q; Liao X; Zhang J; Luo J; Qian H; Duan L; Shi G
    Medicine (Baltimore); 2016 Dec; 95(50):e5565. PubMed ID: 27977588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with secondary immune thrombocytopenia in patients with primary Sjögren's syndrome: a retrospective study of 639 cases.
    Luo J; Song WJ; Chen JQ; Yang GY; Yang JY; Yu XB; Huang ZW; Xu Y; Wang JM; Tao QW
    Clin Exp Rheumatol; 2022 Dec; 40(12):2245-2252. PubMed ID: 35383565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
    Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
    Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
    Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
    J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
    Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
    Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.
    Liu Y; Chen S; Yang G; Wang B; Lan J; Dai F; Rao P; Wu P; Qian H; Shi G
    Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34610996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sjögren syndrome: An observational study.
    Yang W
    Medicine (Baltimore); 2024 May; 103(19):e37909. PubMed ID: 38728456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
    Pamuk ON; Ali SM; Hasni S
    Autoimmun Rev; 2023 Apr; 22(4):103297. PubMed ID: 36781038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
    Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
    Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?
    Iannuccelli C; Spinelli FR; Guzzo MP; Priori R; Conti F; Ceccarelli F; Pietropaolo M; Olivieri M; Minniti A; Alessandri C; Gattamelata A; Valesini G; Di Franco M
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):117-21. PubMed ID: 23261010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndrome.
    Sun F; Tang Q; Cheng W; Xie X; Li F; Chen J
    Int Immunopharmacol; 2023 Oct; 123():110716. PubMed ID: 37506503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
    Tjensvoll AB; Gøransson LG; Harboe E; Kvaløy JT; Omdal R
    Eur J Neurol; 2014 Aug; 21(8):1124-1130. PubMed ID: 24779894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease.
    Fauchais AL; Martel C; Gondran G; Lambert M; Launay D; Jauberteau MO; Hachulla E; Vidal E; Hatron PY
    Autoimmun Rev; 2010 Jul; 9(9):595-9. PubMed ID: 20457283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus].
    Balsalobre Aznar J; Herráez Herrera P; Porta Etessam J; Torres Martín C; Bermell Serrano JC; Núñez López R; Mateo Bernardo I; Padrino Martínez JM; Morillas López L
    An Med Interna; 1999 Dec; 16(12):611-4. PubMed ID: 10686711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.